These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2981976)

  • 1. The seroepidemiology of infection due to Epstein-Barr virus in southern India.
    Venkitaraman AR; Lenoir GM; John TJ
    J Med Virol; 1985 Jan; 15(1):11-6. PubMed ID: 2981976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
    Linde A; Andersson J; Lundgren G; Wahren B
    J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune status towards Epstein-Barr virus in a group of Sicilian children.
    Ammatuna P; Di Stefano R; Arista S; Sammartano F; Bellia L; Formica P; Albeggiani A
    Eur J Epidemiol; 1989 Jun; 5(2):219-23. PubMed ID: 2548891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
    Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
    J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections due to the human herpesviruses in southern India: a seroepidemiological survey.
    Venkitaraman AR; Seigneurin JM; Lenoir GM; John TJ
    Int J Epidemiol; 1986 Dec; 15(4):561-6. PubMed ID: 3028971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-barr virus VCA IgM and EBNA IgG antibodies titered by immunofluorescence in microplates. A semi-automated method based on microtiter system.
    Lamy ME; Favart AM; Leclercq MF; Segas M; Mendez M; Lhoir C; Cornu C; Burtonboy G
    Med Microbiol Immunol; 1982; 170(4):247-53. PubMed ID: 6285158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus serology in bone marrow transplantations: a one-year retrospective study with detection of EBV IgM-VCA-specific antibodies.
    Morinet F; Icart J; Ruelle C; Gluckman E; Perol Y
    J Med Virol; 1986 Apr; 18(4):349-60. PubMed ID: 3011981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological evidence for active Epstein-Barr virus infection in multifocal choroiditis.
    Bhende PS; Biswas J; Madhavan HN
    Indian J Pathol Microbiol; 1997 Apr; 40(2):129-31. PubMed ID: 9257497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Epstein Barr virus (EBV) antibodies: IgG and IgM anti-VCA, IgG anti-EA and Ig anti-EBNA obtained with an original microtiter technique: --serological criterions of primary and recurrent EBV infections and follow-up of infectious mononucleosis--seroepidemiology of EBV in Belgium based on 5178 sera from patients.
    Lamy ME; Favart AM; Cornu C; Mendez M; Segas M; Burtonboy G
    Acta Clin Belg; 1982; 37(5):281-98. PubMed ID: 6297194
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N; Høier-Madsen M; Kangro H
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.
    Hyöty H; Räsänen L; Hiltunen M; Lehtinen M; Huupponen T; Leinikki P
    APMIS; 1991 Apr; 99(4):359-63. PubMed ID: 1645169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology.
    Andersson A; Vetter V; Kreutzer L; Bauer G
    J Med Virol; 1994 Jul; 43(3):238-44. PubMed ID: 7931184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous reactivation of Epstein-Barr virus infections.
    Sumaya CV
    J Infect Dis; 1977 Mar; 135(3):374-9. PubMed ID: 191540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.